Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy

Top Cited Papers
Open Access
Abstract
Microvascular dysfunction, reflected by an inadequate increase in myocardial blood flow in response to dipyridamole infusion, is a recognized feature of hypertrophic cardiomyopathy. Its long-term effect on the prognosis is unknown. We prospectively evaluated a cohort of patients with hypertrophic cardiomyopathy after they had undergone quantitative assessment of myocardial blood flow by positron-emission tomography (PET).

This publication has 35 references indexed in Scilit: